Brian Conway, MD
Cardiovascular Disease · Dallas, TXNPI 1699209106
Payments from drug & device makers
Across 142 payments — averaging $120.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Abbott$2K
- Edwards Lifesciences$2K
- Abiomed$892
- Boston Scientific$603
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$385
- plus $3K from 31 others
What the payments were for
- Grants$8,00047%
- Travel & lodging$2,93217%
- Food & beverage$5,73834%
- Education$3772%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 4 | $8,349 |
| Abbott | 17 | $2,223 |
| Edwards Lifesciences | 29 | $1,871 |
| Abiomed | 16 | $892 |
| Boston Scientific | 4 | $603 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $385 |
| Boehringer Ingelheim | 4 | $347 |
| Irhythm Technologies, Inc. | 2 | $313 |
| Shockwave Medical, Inc | 5 | $304 |
| Kestra Medical Technology Services, Inc. | 4 | $269 |
| Merck | 8 | $176 |
| Bayer | 6 | $152 |
| Cordis US CORP. | 1 | $102 |
| Actelion Pharmaceuticals US, Inc. | 3 | $100 |
| Heartflow, Inc. | 1 | $88 |
| Cathworks, Inc. | 1 | $84 |
| Lantheus Medical Imaging, Inc. | 1 | $76 |
| Terumo Medical Corporation | 2 | $75 |
| Penumbra, Inc. | 1 | $63 |
| Inspire Medical Systems, Inc. | 1 | $55 |
| Bridgebio Pharma, Inc. | 2 | $53 |
| Gilead | 1 | $45 |
| Novartis | 2 | $43 |
| Biosense Webster, Inc. | 1 | $39 |
| Pfizer | 2 | $38 |
| Teleflex LLC | 1 | $34 |
| Amgen | 2 | $31 |
| Novo Nordisk | 1 | $30 |
| Sensible Medical Innovations Inc | 1 | $28 |
| Baxter Healthcare | 1 | $27 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $26 |
| E.r. Squibb & Sons, L.L.C. | 1 | $25 |
| Johnson & Johnson | 1 | $23 |
| Philips North America LLC | 1 | $23 |
| GSK | 1 | $22 |
| Acist Medical Systems, Inc. | 1 | $18 |
| Vital Connect, Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMPLATZER AMULET$1,032
- TRICLIP$585
- Edwards SAPIEN 3 Transcatheter Heart Valve$327
- ONYX FRONTIER$322
- ZIO XT Patch$313
- Impella$298
- HeartMate 3 Left Ventricular Assist Device$212
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$176
- SAPIEN 3 Ultra RESILIA$172
- Farapulse$149
- Assure WCD$149
- JARDIANCE$114
- MYNX CONTROL$102
How this compares
$17,047 in reported general payments places this provider in the 75th percentile of 1,515 cardiovascular disease providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 25 | $450 |
| Atorvastatin Calcium | 24 | $218 |
| Metoprolol Succinate | 12 | $174 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Dallas
- Ramin Farzaneh-FarDallas$17.1M
- Jeffrey GladdenDallas$15.8M
- Ann NavarDallas$14.5M
- Justin GrodinDallas$6.2M
- Ambarish PandeyDallas$2.9M
- Paul GrayburnDallas$1.8M
- Parag KaleDallas$1.5M
- Eric PetersonDallas$1.4M
- Parag JoshiDallas$1.4M
- Darren McGuireDallas$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.